Skip to main content

Adding veliparib to doublet therapy for NSCLC gives slight boost in PFS

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Adding veliparib to doublet therapy for NSCLC gives slight boost in PFS

User login

Username

Password

Reset your password

Type	Lead	score